Media contributions
1Media contributions
Title Study compares Mounjaro to Wegovy for weight loss Degree of recognition National Media name/outlet NewsGP Media type Web Country/Territory Australia Date 5/12/24 Description A new clinical trial, sponsored by the manufacturer, found Mounjaro led to greater weight loss, but GPs warn of its ‘risks of biases’...
Chair of the REC–QC Professor Mark Morgan described the trial as ‘open-label and therefore subject to potential biases’.
The research’s release comes after a separate, much larger-scale cohort study of 41,000 people investigated differences in weight loss between patients receiving tirzepatide compared with semaglutide.
‘In this population of adults with overweight or obesity, use of tirzepatide was associated with significantly greater weight loss than semaglutide,’ the study concluded.
‘Future study is needed to understand differences in other important outcomes.’
But in this study too, Professor Morgan said ‘detail was lacking about safety and side effects’.Producer/Author Dr Manisha Fernando URL https://www1.racgp.org.au/newsgp/clinical/study-compares-mounjaro-to-wegovy-for-weight-loss?utm_source=racgpnewsgpnewsletter&utm_campaign=newsgpedm&utm_medium=email Persons Mark Morgan